Why We Sold Walmart-It’s Not Why You Think

Introduction Walmart’s stock price took a bath early last week, and there are a lot of opinions regarding where the stock price now sits.  The catalyst was their 4th quarter and fiscal year-end 2018 annual report (note: Walmart has a January 31 fiscal year end).  The following headlines courtesy of “Google Finance” illustrate the variance Read more about Why We Sold Walmart-It’s Not Why You Think[…]

Peter Lynch Taught Me to Invest in Ultra Beauty Inc.

Introduction In his best-selling book “One up on Wall Street” Peter Lynch included this subtitle on his cover: “How to use what you already know to make money in the stock market.”  And later in the book he talks about “the power of common knowledge.”  Stating it over simplistically, Peter Lynch often talked about getting Read more about Peter Lynch Taught Me to Invest in Ultra Beauty Inc.[…]

Owens & Minor Inc.: Irresistible Yield, Irresistible Valuation

Introduction Recently, I have had several requests to write an article about Owens & Minor Inc (OMI).  I had not looked at this company in a while, and boy oh, boy, was I surprised at what I found.  Owens & Minor is on the “Dividend Contender” list produced by David Fish. Owens & Minor has Read more about Owens & Minor Inc.: Irresistible Yield, Irresistible Valuation[…]

Invest In Walgreens Or CVS – Speculate In Rite Aid

Introduction For many years now, investing in healthcare related stocks has presented me with a conundrum of sorts.  Demographic forces, primarily the graying of America (and the world for that matter), suggests powerful future growth potential and demand for healthcare related products and services.  On the other hand, healthcare and its costs have long been Read more about Invest In Walgreens Or CVS – Speculate In Rite Aid[…]

Mister Valuation plans for 2018: A New Year a New and Better Approach

The Principles of Valuation: A Year-Long Series Elaborating On Sound Value Investing Principles Introduction Every year I take the holidays off in order to reflect on what I have accomplished for the year, but more importantly, to think deeply about and contemplate what I might do better in the upcoming New Year. This process has Read more about Mister Valuation plans for 2018: A New Year a New and Better Approach[…]

Celgene: Growth At A Reasonable Price Even On Revised Guidance

Introduction This article is an update to my original article on Celgene (CELG) published on June 22, 2017.  Celgene reported their financial results yesterday October 26, 2017, and although the quarter was good, lowered guidance crushed the stock price.  In my opinion, some of the sag in price was justified, but for the most part Read more about Celgene: Growth At A Reasonable Price Even On Revised Guidance[…]

Are These 5 Dow Stocks As Cheap As They Appear?: Part 5 of 5

Introduction This is the final installment of the five-part series where I examined the past operating histories and valuations of the 30 Dow Jones Industrial Average stocks.  With this 5 Part series I attempted to cover the 30 Dow stocks in order of highest valuations to lowest.  For the most part, I suggested that the Read more about Are These 5 Dow Stocks As Cheap As They Appear?: Part 5 of 5[…]

Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5

Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average.  What we found so far were that the majority of these constituents are currently overvalued or at least fully valued.  Finally, with this Part 4, we will Read more about Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5[…]

6 More Expensive Stocks in the Dow Jones Industrial Average: Part 2 of 5

Introduction In part 1 of this five-part series, I covered what I considered the 6 most expensive stocks in the Dow Jones Industrial Average Index of 30 stocks.  With this part 2, I’m going to cover 6 additional Dow stocks that I consider overvalued currently.  So far, these two articles represent approximately 40% of the Read more about 6 More Expensive Stocks in the Dow Jones Industrial Average: Part 2 of 5[…]

The 6 Most Expensive Stocks in the Dow Jones Industrial Average: Part 1 of 5

Introduction When the Dow Jones Industrial Average first hit 20,000 in January of this year it generated quite a buzz within the financial community.  Since January the Dow Jones Index has continued to rise and currently is over 22,700.  However, the Dow Jones is not the only market index that is currently sitting at or Read more about The 6 Most Expensive Stocks in the Dow Jones Industrial Average: Part 1 of 5[…]